The Zacks Analyst Blog UnitedHealth, Chevron, AstraZeneca, Adobe and PfizerZacks Investment Research • 10/12/23
Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing CancersPRNewsWire • 10/12/23
AstraZeneca Awards Funding to Eight Innovative Research Projects From Early-Career Scientists Around the World in Second R&D Postdoctoral ChallengeBusiness Wire • 10/12/23
AstraZeneca advances scientific leadership across multiple cancers with first data from four pivotal Phase III trials at ESMOBusiness Wire • 10/11/23
Astrazeneca Foundation Awards 12 Nonprofit Organizations More Than $2M to Advance Health EquityBusiness Wire • 10/10/23
2 Nasdaq 100 Stocks That Are Surefire Buys in October, and 1 to Avoid Like the PlagueThe Motley Fool • 10/06/23
AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 MillionForbes • 10/03/23
As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical momentMarket Watch • 09/29/23
AstraZeneca ADSs Rise After Reporting Positive Results in Breast Cancer Drug TrialInvestopedia • 09/22/23
AstraZeneca Surges To 50-Day Line After Breast Cancer Drug Tops ChemoInvestors Business Daily • 09/22/23